Further to my post 31/10 re Dixon's exciting announcements of...

  1. 34 Posts.
    Further to my post 31/10 re Dixon's exciting announcements of deal with Kunovus. Their KT009 patents are U.S. only, old circa 2007, and unproven. Kunovus didn't pursue commercializing KT009, instead they have taken a different approach to the disc degeneration problem. They have four new patents for tissue prosthesis insertion system. Also Medigard doesn't have any special syringe technology - ceased - expired. The whole deal is a pointless exercise. More detailed comment to come.
     
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.